Financial Review: Treace Medical Concepts (NASDAQ:TMCI) versus Koninklijke Philips (NYSE:PHG)

Koninklijke Philips (NYSE:PHG – Get Free Report) and Treace Medical Concepts (NASDAQ:TMCI – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings.

Risk & Volatility

Koninklijke Philips has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500.

Earnings & Valuation

This table compares Koninklijke Philips and Treace Medical Concepts”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Koninklijke Philips $20.17 billion 1.39 $1.01 billion $1.17 24.46
Treace Medical Concepts $212.69 million 1.33 -$59.00 million ($0.86) -5.01

Koninklijke Philips has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Koninklijke Philips and Treace Medical Concepts, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips 0 5 0 0 2.00
Treace Medical Concepts 1 1 3 0 2.40

Treace Medical Concepts has a consensus price target of $6.17, indicating a potential upside of 43.08%. Given Treace Medical Concepts’ stronger consensus rating and higher possible upside, analysts clearly believe Treace Medical Concepts is more favorable than Koninklijke Philips.

Institutional & Insider Ownership

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Koninklijke Philips and Treace Medical Concepts’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Koninklijke Philips 5.40% 14.86% 6.20%
Treace Medical Concepts -27.44% -72.99% -29.19%

Summary

Koninklijke Philips beats Treace Medical Concepts on 8 of the 14 factors compared between the two stocks.

About Koninklijke Philips

(Get Free Report)

Koninklijke Philips N.V., commonly known as Philips, is a Netherlands-based health technology company. It develops products and services for hospitals, health professionals and consumers, with offerings that include diagnostic imaging systems such as MRI, CT and ultrasound equipment, image-guided therapy technologies, and patient monitoring solutions. The company also provides connected care and personal health products, including sleep and respiratory care devices, oral healthcare products and grooming appliances.

About Treace Medical Concepts

(Get Free Report)

Treace Medical Concepts, Inc. develops and markets medical devices for foot and ankle surgery, with a focus on treatments for bunions and related deformities. Its products are designed for use by surgeons in correcting and stabilizing bones and joints in the foot. The company’s offerings include the Lapiplasty 3D Bunion Correction System, which uses specialized instruments and fixation implants to support correction of bunion deformities in three dimensions. Treace also sells systems and implants for other foot and ankle procedures, including treatments for deformities involving the midfoot and big toe.

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.